Results 121 to 130 of about 396 (132)
Some of the next articles are maybe not open access.

Monitoring of weekly IGF-I levels during long-acting growth hormone therapy with somapacitan

Endocrine Abstracts, 2020
Kildemoes Rasmus Juul   +3 more
openaire   +1 more source

Somapacitan expected to provide IGF-I levels suitable for once-weekly dosing in children

Endocrine Abstracts, 2017
Rasmus Juul   +3 more
openaire   +1 more source

Single Center Somapacitan Experience

Endocrine Practice
openaire   +1 more source

Le somapacitan (Sogroya®), une nouvelle hormone de croissance

Actualités Pharmaceutiques
Jacques Buxeraud, Sébastien Faure
openaire   +1 more source

Pharmacokinetics of somapacitan in individuals with hepatic impairment: an open-label, parallel group, phase 1 study

Endocrine Abstracts, 2019
Damholt Birgitte Bentz   +3 more
openaire   +1 more source

Wachstumshormon Somapacitan zur einmal wöchentlichen Gabe verfügbar

Pädiatrie
openaire   +1 more source

Pharmacokinetics of somapacitan in individuals with renal impairment: an open-label, parallel group, phase 1 study

Endocrine Abstracts, 2019
Damholt Birgitte Bentz   +3 more
openaire   +1 more source

Utilizing Somapacitan, a Long-Acting Growth Hormone Formulation, for the Treatment of Adult Growth Hormone Deficiency: A Guide for Clinicians

Endocrine Practice
Kevin Yuen
exaly  

Seven-Year Safety and Efficacy of Somapacitan in Children With Growth Hormone Deficiency: Final Results From REAL 3

Journal of the Endocrine Society
Tadej Battelino   +2 more
exaly  

Safety and Efficacy of Somapacitan in Adults With Growth Hormone Deficiency Who Were Switched From Daily Growth Hormone Therapy: A Systematic Review and Meta-Analysis

Growth Hormone and IGF Research
Subhankar Chatterjee   +2 more
exaly  
growth hormone
long-acting growth hormone
adult growth hormone deficiency
somatrogon
growth hormone deficiency
short stature
previous   11  12  13  14  

Home - About - Disclaimer - Privacy